Trials / Terminated
TerminatedNCT02300870
Myocardial Perfusion Echocardiography to Detect Human Heart Transplant Rejection
Myocardial Perfusion Echocardiography to Detect Human Heart Transplant
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 10 (actual)
- Sponsor
- Brigham and Women's Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this proposal is to show the efficacy of contrast enhanced ultrasonography in detecting heart transplant rejection in humans. The secondary objective is to demonstrate the efficacy of this technique in generating data which allow for the assessment of short and long term outcomes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Optison | Echocardiogram with IV contrast |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2019-12-01
- Completion
- 2019-12-01
- First posted
- 2014-11-25
- Last updated
- 2023-07-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02300870. Inclusion in this directory is not an endorsement.